home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  March 28, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 470 active entries

Bio-Synthesis

612 East Main Street Lewisville, TX 75057
75057
United States of America, Texas

Phone: 972-420-8505
Fax: 972-420-0442

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: catalogpep
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

As a pioneer in oligonucleotide synthesis, Bio-Synthesis has been pursuing the development of new oligonucleotide-based techniques that can produce compounds with superior binding affinity and chemical/biological stability. As such, Bio-Synthesis has introduced a third generation of nucleic acid analogs, Bridged Nucleic Acid (BNA).  These are RNA analogues which can be synthesized and spiked with DNA or RNA in order to modify the formation of nucleic acid helices. 
 
 


Selected Categories:
Product Company   Service Company
Biopharma
- General
- Research
Biotech
- General
- Research
Laboratory
- Analytical
- Maintenance

Last update of this entry: October 13, 2014

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.